Live Breaking News & Updates on Jose Carlos Jc Gutierrez Ramos

Danaher Announces Executive Appointment
Share this article
Share this article
WASHINGTON, Dec. 21, 2020 /PRNewswire/  Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ( JC ) Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos will have responsibility for helping define Danaher s science and technology strategy across the organization, including facilitating innovation and further development of scientific and technology talent. With this appointment, Dr. Gutierrez-Ramos will become an executive officer of the Company and report directly to Rainer M. Blair, President and Chief Executive Officer.
Mr. Blair stated, JC brings tremendous scientific and technological expertise to Danaher. The depth of his experience combined with his innovation leadership will be important contributions as we continue to build a stronger, better Danaher. We are excited to welcome JC to the Dan ....

United States , Rainerm Blair , Jose Carlos Jc Gutierrez Ramos , Spanish Scientific Research Council , Basel Institute For Immunology , National Center , Avidia Amgen Inc , Harvard Medical School , Max Plank Institute For Immunbiologie , Millennium Pharmaceuticals Inc , Pfizer Inc , Blood Research , Immunology Department Of The Center , Department Of Genetics , Danaher Corporation , Senior Vice President , Chief Scientific Officer , Chief Executive , Global Drug Discovery , Repertoire Immune Medicines , Amgen Inc , Millennium Pharmaceuticals , Basel Institute , Postdoctoral Fellow , Max Plank Institute , Immunology Department ,